Dose-finding and efficacy confirmation trial of superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for patients with locally advanced maxillary sinus cancer (JCOG1212, RADPLAT-MSC)

Homma, Akihiro; Nakamura, Kenichi; Matsuura, Kazuto; Mizusawa, Junki; Onimaru, Rikiya; Fukuda, Haruhiko; Fujii, Masato

Dose-finding and efficacy confirmation trial of superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for patients with locally advanced maxillary sinus cancer (JCOG1212, RADPLAT-MSC)

Homma, Akihiro; Nakamura, Kenichi; Matsuura, Kazuto et al.

Japanese Journal Of Clinical Oncology, 2015, 45(1), 119-122

Permalink : https://hdl.handle.net/2115/59591

このアイテムのアクセス数:1,318件（2026-08-13 00:38 集計）

閲覧可能ファイル

ファイル	フォーマット	サイズ	閲覧回数	説明
FINAL_20140901_JCOG1212_JJCO_clinical_note	pdf	304 KB	876

論文情報

ファイル出力 EndNote Basic出力 Mendeley出力

アクセス権	open access
URI	https://hdl.handle.net/2115/59591
タイトル	Dose-finding and efficacy confirmation trial of superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for patients with locally advanced maxillary sinus cancer (JCOG1212, RADPLAT-MSC)
著者	Homma, Akihiro ; Nakamura, Kenichi ; Matsuura, Kazuto ; Mizusawa, Junki ; Onimaru, Rikiya ; Fukuda, Haruhiko ; Fujii, Masato
e-Rad_Researcher 30312359 著者名 Homma, Akihiro
著者名 Nakamura, Kenichi
著者名 Matsuura, Kazuto
著者名 Mizusawa, Junki
e-Rad_Researcher 80374461 著者名 Onimaru, Rikiya
著者名 Fukuda, Haruhiko
e-Rad_Researcher 70129633 著者名 Fujii, Masato
言語	英語
キーワード	maxillary sinus cancer
	squamous cell carcinoma
	chemoradiotherapy
	intra-arterial
	cisplatin
発行日	2015-01
出版者	Oxford University Press
収録物名	Japanese Journal Of Clinical Oncology
巻(号)	45(1)
ページ	119-122
抄録	A dose-finding and efficacy confirmation trial was started in Japan in April 2014 to evaluate the efficacy and safety of superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for locally advanced maxillary sinus cancer. A total of 18 patients will be enrolled in the dose-finding phase for the determination of the recommended number of cisplatin cycles, and 65 patients with T4aN0M0 and 62 patients with T4bN0M0, including those who received the recommended number of or fewer cycles in the dose-finding phase, will be enrolled from 16 institutions within a 5-year period in the efficacy confirmation phase. The primary endpoints of the dose-finding and the efficacy confirmation phases are dose-limiting toxicities and 3-year overall survival, respectively. This trial was registered at the UMIN Clinical Trials Registry (http://www.umin.ac.jp/ctr/) under Trial No. UMIN000013706.
資源タイプ	学術雑誌論文
出版タイプ	Accepted Manuscript
権利情報	This is a pre-copyedited, author-produced PDF of an article accepted for publication in Japanese Journal of Clinical Oncology following peer review. The version of record "Dose-finding and efficacy confirmation trial of superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for patients with locally advanced maxillary sinus cancer (JCOG1212, RADPLAT-MSC). Japanese Journal of Clinical Oncology. (2015) 45 (1): 119-122" is available online at: http://dx.doi.org/10.1093/jjco/hyu169
PISSN	0368-2811
関連情報	PMID 25332419
関連情報 (isVersionOf)	出版社版DOI https://doi.org/10.1093/jjco/hyu169